Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 75,218 | 51,239 | 170,667 | 51,039 | 83,155 |
| Marketable Securities | 217,258 | 240,325 | 273,961 | 333,821 | 365,542 |
| TOTAL | $303,386 | $304,415 | $457,124 | $395,364 | $459,115 |
| Non-Current Assets | |||||
| PPE Net | 86,056 | 88,989 | 92,080 | 95,931 | 99,478 |
| Investments And Advances | 80,673 | 111,821 | 1,134 | 15,121 | 3,645 |
| Other Non-Current Assets | 78,595 | 83,895 | 96,545 | 79,934 | 80,599 |
| TOTAL | $245,324 | $284,705 | $189,759 | $190,986 | $183,722 |
| Total Assets | $548,710 | $589,120 | $646,883 | $586,350 | $642,837 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,394 | 5,506 | 12,936 | 5,779 | 5,897 |
| Accrued Expenses | 30,129 | 27,065 | 24,369 | 25,029 | 31,182 |
| TOTAL | $35,523 | $32,571 | $37,305 | $30,894 | $37,079 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 86 | N/A |
| Other Non-Current Liabilities | 91,008 | 92,801 | 94,540 | 94,089 | 93,525 |
| TOTAL | $91,008 | $92,801 | $94,540 | $94,089 | $93,525 |
| Total Liabilities | $126,531 | $125,372 | $131,845 | $124,983 | $130,604 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 217,265 | 209,672 | 209,112 | 170,853 | 169,092 |
| Common Shares | 212 | 210 | 209 | 170 | 169 |
| Retained earnings | -1,819,823 | -1,759,884 | -1,693,591 | -1,627,233 | -1,562,233 |
| Other shareholders' equity | -89 | 157 | -780 | -927 | -955 |
| TOTAL | $422,179 | $463,748 | $515,038 | $461,367 | $512,233 |
| Total Liabilities And Equity | $548,710 | $589,120 | $646,883 | $586,350 | $642,837 |